Business Wire
Profluent
|
Published 
Dec 9, 2025

Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies

XX min read

TL;DR

Sign up for updates on our journey

Oops! Something went wrong while submitting the form.
Business Wire
|
Published 
Dec 9, 2025

More media

All Media